Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM

PHASE4CompletedINTERVENTIONAL
Enrollment

801

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Hypertension
Interventions
DRUG

Telmisartan

DRUG

Ramipril

Trial Locations (62)

1090

Univ.-Klinik für Innere Medizin III, Vienna

1685

Health Emporium, Midrand

1911

Boehringer Ingelheim Investigational Site, Vanderbijlpark

3010

Schweizerisches Herz- und Gefässzentrum, Bern

4031

Universitätsspital Basel, Basel

4055

Boehringer Ingelheim Investigational Site, Basel

6600

Boehringer Ingelheim Investigational Site, Muralto

6900

Cardiocentro Ticino, Lugano

7431

Rehabilitationszentrum für Herz- und Kreislauferkrankungen, Bad Tatzmannsdorf

7531

Boehringer Ingelheim Investigational Site, Bellville

8020

Landeskrankenhaus Graz West, Graz

8036

Medizinische Universitätsklinik Graz, Graz

8596

Boehringer Ingelheim Investigational Site, Münsterlingen

8600

A.ö. Landeskrankenhaus Bruck a. d. Mur, Bruck A. D. Mur

9500

Landeskrankenhaus Villach, Villach

28007

Pabellon de Consultas, Madrid

33006

Edificio de Consultas Externas, Oviedo

33075

Hôpital Saint André, Bordeaux

33112

Boehringer Ingelheim Investigational Site, Saint Laurent Du Medoc

37007

Boehringer Ingelheim Investigational Site, Salamanca

41013

Centro de Diagnostico y Tratamiento, Seville

48680

Hospital de Galdakao, Galdakao / Vizcaya

49000

Boehringer Ingelheim Investigational Site, Angers

49100

Boehringer Ingelheim Investigational Site, Angers

49400

Boehringer Ingelheim Investigational Site, Saumur

49492

Boehringer Ingelheim Investigational Site, Westerkappeln

53000

Boehringer Ingelheim Investigational Site, Laval

53100

Boehringer Ingelheim Investigational Site, Mayenne

73485

Boehringer Ingelheim Investigational Site, Unterschneidheim

76351

Boehringer Ingelheim Investigational Site, Linkenheim-Hochstetten

76571

Boehringer Ingelheim Investigational Site, Gaggenau

78054

Boehringer Ingelheim Investigational Site, Villingen-Schwenningen

83527

Boehringer Ingelheim Investigational Site, Haag

84137

Boehringer Ingelheim Investigational Site, Vilsbiburg

84453

Boehringer Ingelheim Investigational Site, Mühldorf

94447

Boehringer Ingelheim Investigational Site, Plattling

2121 BB

Boehringer Ingelheim Investigational Site, Bennebroek

6415 HT

Boehringer Ingelheim Investigational Site, Heerlen

7441 BN

Boehringer Ingelheim Investigational Site, Nijverdal

3082 DC

Boehringer Ingelheim Investigational Site, Rotterdam

0143

1 Military Hospital, Vootrekkehoogte

08003

Boehringer Ingelheim Investigational Site, Barcelona

08923

Pabellon B / 1 piso, Santa Coloma de Gramanet

TW15 3EA

Boehringer Ingelheim Investigational Site, Ashford

CV9 1EU

Boehringer Ingelheim Investigational Site, Atherstone

BA2 3HAT

Boehringer Ingelheim Investigational Site, Bath

CV6 4DD

Boehringer Ingelheim Investigational Site, Bedworth

CV7 8LA

Boehringer Ingelheim Investigational Site, Coventry

DN1 2EG

Boehringer Ingelheim Investigational Site, Doncaster

PL23 1DT

Boehringer Ingelheim Investigational Site, Fowey

BA11 2QE

Boehringer Ingelheim Investigational Site, Frome

G69 7AD

Boehringer Ingelheim Investigational Site, Glasgow

IG3 8BG

Boehringer Ingelheim Investigational Site, Ilford

KY6 3LG

Boehringer Ingelheim Investigational Site, Lesley

PL22 0EF

Boehringer Ingelheim Investigational Site, Lostwithiel

CV32 4RA

Boehringer Ingelheim Investigational Site, Royal Leamington Spa

PO33 2PT

Boehringer Ingelheim Investigational Site, Ryde

BA14 7EG

Boehringer Ingelheim Investigational Site, Trowbridge

NR23 1JP

Boehringer Ingelheim Investigational Site, Wells Next to the Sea

CT5 1BZ

Boehringer Ingelheim Investigational Site, Whitstable

CT5 3QU

Boehringer Ingelheim Investigational Site, Whitstable

YO31 8HE

York District Hospital, York

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY